Viridian Therapeutics Inc (LTS:0K1R) Stock News, Headlines & Updates
Viridian Therapeutics Inc Stock News from GuruFocus
- 1
Aug 08, 2024
Viridian Therapeutics Highlights Recent Progress and Reports Second Quarter 2024 Financial Results
Business Wire • 8:00am
Viridian Therapeutics Inc (VRDN) Q2 2024 Earnings: EPS of -$1.02 Misses Estimates, Revenue Falls Short at $72,000
GuruFocus Research • 7:51am
Aug 07, 2024
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire • 4:00pm
Jul 25, 2024
Viridian Therapeutics Announces Completion of THRIVE-2 Enrollment for VRDN-001 in Patients with Chronic Thyroid Eye Disease (TED)
Business Wire • 8:00am
Jul 03, 2024
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire • 8:00am
Jun 11, 2024
Viridian Therapeutics Announces Details of Subcutaneous VRDN-003 Phase 3 Clinical Program for Patients with Active and Chronic Moderate-to-Severe Thyroid Eye Disease
Business Wire • 6:00am
Jun 06, 2024
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire • 4:00pm
May 31, 2024
Viridian Therapeutics Announces Participation in Upcoming June Investor Conferences
Business Wire • 8:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news